GenSight Biologics
SIGHT.PA
#9645
Rank
A$59.84 M
Marketcap
$0.46
Share price
-4.78%
Change (1 day)
-31.74%
Change (1 year)

Earnings for GenSight Biologics (SIGHT.PA)

Earnings in 2024: -A$22.72 Million

According to GenSight Biologics's latest financial reports the company's current earnings are A$1.56 Million. In 2024 the company made an earning of -A$22.72 Million, an increase over its 2023 earnings that were of -A$45.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for GenSight Biologics from 2013 to 2024

Annual earnings

Year Earnings Change
2024-A$22.72 Million-49.81%
2023-A$45.26 Million-2.16%
2022-A$46.25 Million-8.58%
2021-A$50.59 Million-22.54%
2020-A$65.32 Million21.01%
2019-A$53.98 Million-9.66%
2018-A$59.75 Million32.28%
2017-A$45.17 Million24.57%
2016-A$36.26 Million55.57%
2015-A$23.31 Million84%
2014-A$12.67 Million112.64%
2013-A$5.96 Million